ANN ARBOR, Mich.--(BUSINESS WIRE)--Millendo Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing novel treatments for endocrine diseases, today announced that Julia C. Owens, Ph.D., President and Chief Executive Officer, will present at the Oppenheimer 28th Annual Healthcare Conference on Wednesday, March 21, 2018 at 3:55 PM ET in New York, NY.
About Millendo Therapeutics, Inc.
Millendo Therapeutics is
focused on developing novel treatments for endocrine diseases. Our
mission is to build a leading endocrine company that creates distinct
and transformative treatments for a wide range of diseases where there
is a significant unmet medical need. We are currently advancing
livoletide for the treatment of Prader-Willi syndrome and nevanimibe for
the treatment of classic congenital adrenal hyperplasia and endogenous
Cushing’s syndrome. www.millendo.com